Form 4: Twist Bioscience CEO Emily Leproust Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
CEO of Twist Bioscience, Emily Leproust, sold 5,042 shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units.
Summary
- On May 5, 2025, Emily M. Leproust, CEO of Twist Bioscience, sold 5,042 shares of common stock at a price of $37.651 per share.
- The sale was mandated by the issuer to cover tax withholding obligations related to the vesting of Restricted Stock Units.
- Leproust continues to hold 655,432 shares of Twist Bioscience common stock directly.
- Leproust also holds employee stock options with varying exercise prices and expiration dates.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a stock sale to cover tax obligations. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This filing indicates a sale of shares by the CEO to cover tax obligations, which is a common practice.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on shareholders, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 12/19/2022 | Performance stock options vested and became exercisable. |
| 05/05/2025 | Emily Leproust sold 5,042 shares of common stock. |
| 05/07/2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, TWST, Twist Bioscience, Emily Leproust, Stock Sale, CEO, Tax Withholding, Restricted Stock Units, Employee Stock Options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.